TransMedics (TMDX) Convertible Debt (2023 - 2026)

TransMedics' Convertible Debt history runs 4 years deep, the most recent figure standing at $453.5 million for Q1 2026.

• In Q1 2026, Convertible Debt rose 0.64% year-over-year to $453.5 million; the TTM figure through Mar 2026 stood at $453.5 million (up 0.64% YoY), while the FY2025 annual figure was $452.8 million, up 0.64% from the prior year.
• Convertible Debt was $453.5 million for Q1 2026 at TransMedics, roughly flat from $452.8 million in the prior quarter.
• In the past five years, Convertible Debt ranged from a high of $453.5 million in Q1 2026 to a low of $445.8 million in Q2 2023.
• Historically, Convertible Debt has averaged $449.6 million across 4 years, with a median of $449.6 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Convertible Debt gained 0.62% in 2024, then advanced 0.64% in 2026.
• A 4-year view of Convertible Debt shows it stood at $447.1 million in 2023, then grew by 0.63% to $449.9 million in 2024, then gained by 0.64% to $452.8 million in 2025, then grew by 0.16% to $453.5 million in 2026.
• The last three Convertible Debt figures came in at $453.5 million (Q1 2026), $452.8 million (Q4 2025), and $452.1 million (Q3 2025), per Business Quant data.